HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.8%

Neg 0% Neu 91.8% Pos 0%

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $46 price target.